About Pharma Twittersphere
The pharma twitter study series is the most extensive study undertaken to date: a benchmark of 15 pharma twitter accounts and their over 50,000 followers! All accounts benchmarked were Global corporate communication accounts, except for selected US accounts that were included. The study objectives are to analyze who follows pharma twitter accounts: segmenting followers by stakeholder, activity and therapeutic area interest.
Pharma Twittersphere Overview
In this report, we quantify the twitter opportunity in order to make a more sound case for twitter versus other traditional media channels.
How does the pharma presence on twitter compare to other industries? To overall twitter followers?
To what degree do followers overlap between pharma companies? What is the reach of followers and what engagement can we expect?
Pharma Twittersphere Geography
This report focuses on the geographical make up of pharma twitter accounts, as well as how pharma twitter accounts compare to one another in terms of geography.
Where are followers located? How does the geographic make up of followers compare to overall twitter statistics or the countries’ population? Amongst pharma accounts? Where does localization of twitter accounts work?
Pharma Twittersphere Engagement Matrix
Engagement is a relationship. You have to invest in it constantly and engage consistently for it to flourish in an atmosphere of mutual trust and respect. This made us wonder: Does it really make a difference whether or not pharma is following back or how frequently companies tweet? Does their engagement on twitter impact the quality of their followers? And how?
Pharma Twittersphere Stakeholders
In this study, we will see that healthcare professionals and patients now directly follow pharma news and updates on twitter. Their reach is much less relevant than the fact that twitter provides a way to directly engage with them. How can stakeholders on twitter be segmented? Which segments are over or underrepresented? How can pharma engage with them?